CLINICAL_TRIALS
trial_result
· 2020-12-19
Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of QAW039 [Phase 2]
Summary
Phase 2 trial update reporting efficacy, safety, and pharmacokinetics of QAW039 in persistent asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Persistent Asthma | Phase 2 | Status: COMPLETED